EPT is developing its 'Patch Technology' at Monash Uni...
Given the collaboration with Monash Uni & Norwood Abbey on it's immunology project (& a 3 % stakeholding in this), there may also be potential for the teaming up with EPT & NAL, given their Laser - patch drug delivery technology.
Anyone have any thoughts on this....?
Then again they may not need the laser technology, since this would perhaps be contrary to their desire to have a 'slow release' & take home method of distribution.
Also I wonder if the patch/ cream idea is not a favourable one as the Melanocytes in the skin in the area of the patch application may recieve a disproportionately higher dose of Melanotan?? Therefore an uneven tan??
Drewe.
NAL Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
